Press release
Chickenpox Vaccine Global Market Predicted to Augment and Reach over $4.64 Billion at a CAGR of 6.5% By 2028 | Pfizer Inc., Novartis AG, Sanofi Pasteur, AstraZeneca plc., GlaxoSmithKline PLC
Chickenpox Vaccine Global Market
The Business Research Company offers in-depth market insights through Chickenpox Vaccine Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The chickenpox vaccine market size has grown strongly in recent years. It will grow from $3.38 billion in 2023 to $3.61 billion in 2024 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to vaccine development, regulatory approvals, disease incidence, vaccination policies, public health initiatives.
The chickenpox vaccine market size is expected to see strong growth in the next few years. It will grow to $4.64 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to public perception and trust, pandemic preparedness, research and development, emerging market demand, healthcare infrastructure development. Major trends in the forecast period include vaccine education campaigns, adverse event monitoring, vaccine pricing strategies, advanced innovation, use of AI.
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=8581&type=smp
Market Segmentation:
The chickenpox vaccine market covered in this report is segmented -
1) By Vaccine: Monovalent varicella vaccine, Combination varicella vaccine
2) By Application: Mumps, Measles, Rubella, And Varicella Immunization, Herpes Zoster Immunization, Chickenpox Vaccination
3) By End-Users: Hospitals, Clinics, Other End-Users
Major Driver - Surge In Chickenpox Cases Driving Growth In Vaccine Market
The rising prevalence of chickenpox disease is expected to propel the growth of the chickenpox vaccine market going forward. Chickenpox disease refers to a severe infectious disease caused by the varicella-zoster virus (VZV) that causes a fluid-filled rash with an itchy rash. Increased cases of chickenpox necessitate more varicella vaccine immunization, thus, increasing demand for chickenpox vaccines. For instance, in April 2021, according to a report published by the Centers for Disease Control and Prevention (CDC), a US-based international public health agency, in the USA, around 4 million people have chickenpox annually, and over 10, 500 of them end up in hospitals, and between 100 and 150 of them pass away. Therefore, the rising prevalence of chickenpox disease is driving the growth of the chickenpox vaccine market.
Competitive Landscape:
Major companies operating in the chickenpox vaccine market report are Pfizer Inc., Merck & Co Inc., Novartis AG, Sanofi Pasteur, AstraZeneca plc., GlaxoSmithKline plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, CSL Limited, Daiichi Sankyo Company Limited, Mitsubishi Tanabe Pharma Corporation, Zydus Lifesciences Limited, Green Cross Corporation, Sinovac Biotech Ltd., GC Biopharma Corp., Emergent BioSolutions Inc., Bharat Biotech, Novo Medi Sciences Pvt. Ltd., Hualan Biological Engineering Inc., Chongqing Zhifei Biological Products Co. Ltd., Walvax Biotechnology Co. Ltd., Bavarian Nordic A/S, Valneva SE, Serum Institute of India, Shenzhen Kangtai Biological Products Co. Ltd., SK Bioscience Co.Ltd., Biological E. Limited, PanGen Biotech Inc., Bio-Med, Parc-vaccinogène en Instituut Pasteur, Lucky Chemical Industrial Corporation, Biocad India Private Limited, Virchow Biotech Pvt. Ltd.
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/chickenpox-vaccine-global-market-report
Top Trend - Leading Vaccine Companies Invest In R&D For Enhanced Chickenpox Formulations And Global Immunization Solutions
Major companies operating in the chickenpox vaccine market are focusing on research and development investments to introduce new vaccine formulations. R&D investments, or research and development investments, refer to the funds allocated by organizations, such as companies, governments, or research institutions, to activities aimed at innovation and advancement in their respective fields. For instance, in February 2022, according to the GOV.UK report, the UK government allocated £10 million for vaccine research to combat potential epidemics in developing countries. This investment is part of a larger commitment to invest £134 million of Official Development Assistance (ODA) between 2016 and 2021 in vaccines for epidemic diseases. 22 research projects have been selected by the government's UK Vaccine Network and will help tackle viruses such as Ebola, Lassa fever, and Zika.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Chickenpox Vaccine Market Characteristics
3. Chickenpox Vaccine Market Trends And Strategies
4. Chickenpox Vaccine Market - Macro Economic Scenario
5. Chickenpox Vaccine Market Size And Growth
…..
27. Chickenpox Vaccine Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chickenpox Vaccine Global Market Predicted to Augment and Reach over $4.64 Billion at a CAGR of 6.5% By 2028 | Pfizer Inc., Novartis AG, Sanofi Pasteur, AstraZeneca plc., GlaxoSmithKline PLC here
News-ID: 3411236 • Views: …
More Releases from The Business research company
Increasing Financial Fraud Incidents Propel Accounting and Auditing Market: A Ke …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Accounting And Auditing Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for accounting and auditing has seen a robust growth in the past few years. It is expected to increase from $222.35 billion in 2024 to $238.28 billion in 2025, reflecting a…
Supply Chain Finance Market Expected to Achieve 8.6% CAGR by 2029: Growth Foreca …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Supply Chain Finance Market Size By 2025?
The market size for supply chain finance has been experiencing a robust expansion in the past few years. The market, which is projected to escalate from $12.47 billion in 2024 to $13.42 billion in 2025, is expected to…
Personal Loans Market on Track for Strong Growth, Estimated to Grow at 10.7% CAG …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Personal Loans Market Through 2025?
The personal loans industry has seen robust growth in recent years. The market size is projected to increase from $778.34 billion in 2024 to $854.94 billion in 2025, with a compound annual growth rate (CAGR) of 9.8%.…
Key Trends Reshaping the Mobile Wallet Market: Revolut Launches Innovative Mobil …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Mobile Wallet Market Size Growth Forecast: What to Expect by 2025?
The scale of the mobile wallet market has experienced a monumental expansion in the past few years. Its morphology will evolve from $2109.19 billion in 2024 to a staggering $2754.87 billion by 2025, reflecting a compound annual growth…
More Releases for Chickenpox
Emerging Trends to Reshape the Chickenpox Vaccine Market: Innovative Drug Develo …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Chickenpox Vaccine Market Through 2025?
The market for the chickenpox vaccine has seen robust growth in the past years. The industry is set to expand from $3.57 billion in 2024 to $3.8 billion in 2025, registering a compound annual growth rate (CAGR)…
Chickenpox Vaccine Market Forecast 2025-2034: Comprehensive Analysis And Growth …
The Chickenpox Vaccine Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Chickenpox Vaccine Market Size and Projected Growth Rate?
There has been robust growth in the chickenpox vaccine market size in the past few years. It is projected to expand from $3.57 billion…
Chickenpox Vaccine Market Size, Share, Trends And Forecast 2024 To 2033
The chickenpox vaccine market size has grown strongly in recent years. It will grow from $3.38 billion in 2023 to $3.61 billion in 2024 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to vaccine development, regulatory approvals, disease incidence, vaccination policies, public health initiatives.
The chickenpox vaccine market size is expected to see strong growth in the next few years. It…
Chickenpox Vaccine Market Trends, Industry Outlook 2024 To 2033
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2219
The Business Research Company presents an extensive market research report on the Chickenpox Vaccine Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.
Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities,…
Chickenpox Vaccine: What Everyone Should Know
Chickenpox vaccines enclosed an attenuated (weakened) live strain of the varicella-zoster (chickenpox) virus. Serious diseases such as herpes zoster and chickenpox can be caused as these vaccines stimulate the immune system against the varicella-zoster virus. Varicella vaccines are of two types namely monovalent and combination varicella vaccines. Absence of chickenpox immunization can lead to complications such as bacterial infections of the skin, joints or bloodstream (sepsis), soft tissues, bones, pneumonia,…
Chickenpox Vaccine Market to see Rapid Growth by 2029
The Chickenpox Vaccine Market size is expected to grow at an annual average of CAGR 4% during the forecast period (2023-2029). Chickenpox is extremely infectious and is typically transferred via direct touch or through the air by coughing and sneezing. The condition is characterized by an itchy rash, as well as headaches, fussiness, and coughing. The chickenpox vaccination, known as the Varicella vaccine, is named after the varicella-zoster virus, which…
